Filter Results :

Your search for antibod returned 144 reports

Sort by


Global Bispecific Antibody Market & Clinical Pipeline Insight 2020

12 Jul 2016  |  Published by:  KuicK Research
"With revolutionization in the medicinal sector and more of inclination towards personalized therapy, the medical world is also witnessing the emergence of advanced analogues of monoclonal antibodies called as Bispecific monoclonal antibodies. As the name signifies the molecules possess “dual ...

$ 2,400.00

Read More

Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other Diseases

03 Jun 2016  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence report about Bispecific Antibodies for Cancer, Inflammatory & Other Diseases evaluates the competitive landscape of bispecific therapeutic antibodies for treatment of cancer, anti-inflammatory & autoimmune diseaseas as well as cardiometabolic, infectious, ...

$ 550.45

Read More

China Monoclonal Antibody Industry 2016 Market Research Report

30 May 2016  |  Published by:  QYResearch
The China Monoclonal Antibody Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Monoclonal Antibody industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. T...

$ 3,200.00

Read More

Competitor Analysis: Biosimilar and Biosuperior Anti-CD20 Antibodies

25 May 2016  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about Biosimilar and Biosuperior Anti-CD20 Antibodies 2016 updates the competitive landscape of biosimilar and biosuperior therapeutic antibodies targeting CD20 in comparison with originator anti-CD20 antibodies to treat solid tumors as well as inflammatory...

$ 330.27

Read More

Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies

25 May 2016  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence report about Biosimilar & Biosuperior Therapeutic Antibodies updates the competitive landscape of biosimilar therapeutic antibodies as of May 2016. The report evaluates the the first wave of biosimilar recombinant monoclonal antibodies in comparison with the ...

$ 1,431.16

Read More

Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies

25 May 2016  |  Published by:  La Merie Business Intelligence
Humira, Enbrel and Remicade were the three best selling blockbuster biologics in the year 2015. Together with Simponi and Cimzia, combined sales of all five anti-TNF antibodies in the year 2015 were US$ 36 bln (+3.9% vs previous year), ahead of combined sales of all cancer antibodies. Marketin...

$ 550.45

Read More

Competitor Analysis: Biosimilar and Biosuperior Anti-Her2 Antibodies

25 May 2016  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence Report about Biosimilar and Biosuperior Anti-Her2 Antibodies 2016 updates the competitive landscape of biosimilar and biosuperior therapeutic antibodies targeting Her2 in comparison with originator anti-Her2 antibodies to treat solid tumors as of May 2016. Purchas...

$ 330.27

Read More

Competitor Analysis: Biosimilar and Biosuperior Anti-EGF-R Antibodies

25 May 2016  |  Published by:  La Merie Business Intelligence
This Competitive Intelligence report about Biosimilar and Biosuperior Anti-EGF-R Antibodies updates the competitive landscape of biosimilar and biosuperior therapeutic antibodies targeting epithelial growth factor receptor (EGF-R) in comparison with originator anti-EGF-R antibodies to treat so...

$ 275.22

Read More

T-Cell Redirecting Bispecific Antibodies 2016: A competitive landscape analysis of stakeholders, technologies, pipelines and deals

11 May 2016  |  Published by:  La Merie Business Intelligence
Immunotherapy of cancer with direct or indirect use of T-cells is one of the most exciting fields of cancer research. Direct T-cell therapy implies the ex vivo engineering of autologous or allogeneic T-cells for tumor targeting by chimeric antigen receptors (CAR) or T-cell receptors (TCR). Des...

$ 2,400.00

Read More

Antibody Target, Technology & Pipeline Database

30 Apr 2016  |  Published by:  La Merie Business Intelligence
Antibody Target, Technology & Pipeline Database: 1-Year Subscription Therapeutic monoclonal antibodies have become a clinically and commercially successful class of drugs. Branded therapeutic antibodies on the market reached global sales of US$ 91.5 bln in the year 2015, with a growth rate ...

$ 1,541.25

Read More

Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021 - Nanoparticles, Polymers, Liposomes, Micelles, Nanoemulsions, Dendrimers, Monoclonal Antibodies by Geography, Therapeutic Area and Stakeholder Environment

04 Apr 2016  |  Published by:  Kelly Scientific Publications
Advanced and Targeted Drug Delivery Market Segmentation, Analysis & Forecast to 2021 Nanoparticles, Polymers, Liposomes, Micelles, Nanoemulsions, Dendrimers, Monoclonal Antibodies by Geography, Therapeutic Area and Stakeholder Environment This newly published report is a global industry ...

$ 4,183.38

Read More

Global Antibody Conjugates Drugs Market 2016-2020

31 Mar 2016  |  Published by:  Technavio-Infiniti Research
About Antibody Drug Conjugates ADCs, empowered monoclonal antibodies (mAbs), use chemical linkers with labile bonds to attach biologically active substances. ADCs target mAbs with the cancer killing ability of cytotoxic drugs, allowing sensitive discernment between healthy and diseased tiss...

$ 2,500.00

Read More

Global Anti-CD20 Monoclonal Antibodies Industry 2016 Market Research Report

18 Mar 2016  |  Published by:  9Dimen Research
2016 Global Anti-CD20 Monoclonal Antibodies Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Anti-CD20 Monoclonal Antibodies industry, focusing on the main regions (North America, Europe and Asia) and the main count...

$ 2,850.00

Read More

Global Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

01 Mar 2016  |  Published by:  CurrentPartnering
The Global Antibody Partnering Terms and Agreements 2010 to 2016 report provides comprehensive understanding and unprecedented access to the Antibody partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and ana...

$ 2,995.00

Read More

Global Monoclonal Antibody Partnering Terms and Agreements 2010-2016: Deal trends, players and financials

01 Mar 2016  |  Published by:  CurrentPartnering
The Global Monoclonal antibody Partnering Terms and Agreements 2010 to 2016: Deal trends, players, financials and forecasts report provides a detailed understanding and analysis of how and why companies enter monoclonal antibody partnering deals. The majority of deals are development stage whe...

$ 2,995.00

Read More
Total 144 records.